Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials

IF 2.7 3区 医学 Q3 ONCOLOGY
Rebecca Moser , Lena Marie Buchecker , Jantje M. Bohlen , Mathias Düsberg , Maximilian Aigner , Nina A. Mayr , Jana Nano , Sophie T. Behzadi , Sophia Kiesl , Marciana-Nona Duma , Markus Oechsner , Stephanie E. Combs , Kai J. Borm
{"title":"Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials","authors":"Rebecca Moser ,&nbsp;Lena Marie Buchecker ,&nbsp;Jantje M. Bohlen ,&nbsp;Mathias Düsberg ,&nbsp;Maximilian Aigner ,&nbsp;Nina A. Mayr ,&nbsp;Jana Nano ,&nbsp;Sophie T. Behzadi ,&nbsp;Sophia Kiesl ,&nbsp;Marciana-Nona Duma ,&nbsp;Markus Oechsner ,&nbsp;Stephanie E. Combs ,&nbsp;Kai J. Borm","doi":"10.1016/j.ctro.2025.100956","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Adjuvant radiotherapy (RT) of left sided breast cancer is increasingly performed in deep inspiration breath hold (DIBH). This technique requires active involvement and compliance of patients as well as pulmonary endurance. Since previous studies focused on female patients with a median age under 65 years to test practicability of DIBH and advantages in comparison to free breathing (FB), DIBH in elderly patients over 65 years remains mostly underexplored. This study aims to evaluate attitudes and feasibility of DIBH in elderly breast cancer patients.</div></div><div><h3>Methods</h3><div>First a 14-item survey of 100 female breast cancer patients aged ≥65 years was conducted to assess their attitudes toward DIBH and their breath-hold capability. Secondly, we performed a matched-pair analyses using pooled data from the prospective GATTUM and B-REST trials to compare respiratory and dosimetric parameters during DIBH between patients aged ≥65 years (n = 30) and &lt;65 years (n = 30).</div></div><div><h3>Results</h3><div>According to the survey large majority of patients were interested in DIBH: 98 % stated that age should not be a criterion when selecting patients for DIBH, and 66 were able to hold their breath &gt; 20 s. Based on the matched-pair analyses of the GATTUM and B-Rest trials, no significant differences were observed regarding breath hold amplitude, duration and stability, and in DIBH-induced dose reduction to organs at risk between elderly (≥65) (n = 30) and younger patients (n = 30).</div></div><div><h3>Conclusion</h3><div>Based on our results age alone should not be used as a criterion for excluding patients from DIBH in the treatment of left-sided breast cancer.</div></div>","PeriodicalId":10342,"journal":{"name":"Clinical and Translational Radiation Oncology","volume":"53 ","pages":"Article 100956"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405630825000461","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Adjuvant radiotherapy (RT) of left sided breast cancer is increasingly performed in deep inspiration breath hold (DIBH). This technique requires active involvement and compliance of patients as well as pulmonary endurance. Since previous studies focused on female patients with a median age under 65 years to test practicability of DIBH and advantages in comparison to free breathing (FB), DIBH in elderly patients over 65 years remains mostly underexplored. This study aims to evaluate attitudes and feasibility of DIBH in elderly breast cancer patients.

Methods

First a 14-item survey of 100 female breast cancer patients aged ≥65 years was conducted to assess their attitudes toward DIBH and their breath-hold capability. Secondly, we performed a matched-pair analyses using pooled data from the prospective GATTUM and B-REST trials to compare respiratory and dosimetric parameters during DIBH between patients aged ≥65 years (n = 30) and <65 years (n = 30).

Results

According to the survey large majority of patients were interested in DIBH: 98 % stated that age should not be a criterion when selecting patients for DIBH, and 66 were able to hold their breath > 20 s. Based on the matched-pair analyses of the GATTUM and B-Rest trials, no significant differences were observed regarding breath hold amplitude, duration and stability, and in DIBH-induced dose reduction to organs at risk between elderly (≥65) (n = 30) and younger patients (n = 30).

Conclusion

Based on our results age alone should not be used as a criterion for excluding patients from DIBH in the treatment of left-sided breast cancer.

Abstract Image

基于前瞻性GATTUM和B-REST试验评估年龄对放疗中DIBH的影响
背景左侧乳腺癌的辅助放疗(RT)越来越多地采用深吸气屏气(DIBH)方式进行。这项技术需要患者的积极参与和依从性以及肺耐力。由于以往的研究主要集中在中位年龄小于65岁的女性患者,以测试DIBH的实用性及其与自由呼吸(FB)相比的优势,因此65岁以上老年患者的DIBH仍未得到充分探索。本研究旨在评估老年乳腺癌患者对DIBH的态度和可行性。方法首先对100例年龄≥65岁的女性乳腺癌患者进行14项调查,评估其对DIBH的态度和屏气能力。其次,我们使用前瞻性GATTUM和B-REST试验的汇总数据进行配对分析,比较≥65岁(n = 30)和≥65岁(n = 30)患者在DIBH期间的呼吸和剂量学参数。结果根据调查,绝大多数患者对DIBH感兴趣:98%的患者表示年龄不应成为选择DIBH患者的标准,66名患者能够屏住呼吸。20年代。根据GATTUM和B-Rest试验的配对分析,老年人(≥65岁)(n = 30)和年轻患者(n = 30)在屏气幅度、持续时间和稳定性以及dibh对危险器官的剂量减少方面没有观察到显著差异。结论根据我们的研究结果,年龄不应该单独作为排除左侧乳腺癌治疗中DIBH患者的标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
5.30
自引率
3.20%
发文量
114
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信